Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Marker for Iron Availability Derived From Blood Test

By LabMedica International staff writers
Posted on 18 Jul 2011
Low hemoglobin density (LHD%) is a new parameter provided by an autoanalyzer that can be derived from the mean cell hemoglobin concentration.

The diagnosis of iron deficiency or functional iron deficiency is particularly challenging in patients with acute or chronic inflammatory conditions because most of the biochemical markers for iron metabolism are affected by acute phase reaction.

Scientists at the Hospital Galdakao – Usansolo, (Galdakao, Spain), used the program of the LH 780 analyzer to study 110 patients with iron deficiency (IDA); 65 with chronic kidney disease (CKD), and 85 with anemia of chronic disease (ACD), 24 of whom were iron deficient and 61 were iron sufficient and 90 healthy subjects. A total of 350 peripheral blood samples were analyzed during the 2-month period from March 2010 to April 2010.

Low hemoglobin density values showed no statistical difference in patients with IDA and patients with ACD accompanied with IDA. The LHD% values in these patients were significantly different compared with the iron-sufficient patients with ACD. Receiver operating characteristic (ROC) curve analysis for LHD% in the detection of iron deficiency showed the following: area under curve 0.903; cut off 5.5%, with a sensitivity of 88.6%, and a specificity of 76.9%.

The author concluded that in the present study the parameter, LHD% is useful for diagnosing iron deficiency and is a reliable parameter for recognizing subsets of anemic patients and therefore improving the diagnosis and management of anemia. The LHD% analysis can be performed simultaneously in the course of routine blood counts, with no incremental costs and no additional blood sampling. In conjunction with standard blood cell counts and iron parameters, LHD% could enable the diagnosis to be made rapid and accurately, when using the LH 780 analyzer (Beckman Coulter Inc., Miami, FL, USA). The study was published on July 4, 2011, in the International Journal of Laboratory Hematology.

Related Links:

Hospital Galdakao – Usansolo
Beckman Coulter Inc.



Gold Member
Chagas Disease Test
CHAGAS Cassette
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Silver Member
ACTH Assay
ACTH ELISA
New
Dermatophytosis Rapid Diagnostic Kit
StrongStep Dermatophytosis Diagnostic Kit
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get complete access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The experimental blood test accurately indicates severity and predicts potential recovery from spinal cord injury (Photo courtesy of 123RF)

Blood Test Identifies Multiple Biomarkers for Rapid Diagnosis of Spinal Cord Injury

The National Institutes of Health estimates that 18,000 individuals in the United States sustain spinal cord injuries (SCIs) annually, resulting in a staggering financial burden of over USD 9.... Read more

Immunology

view channel
Image: The findings were based on patients from the ADAURA clinical trial of the targeted therapy osimertinib for patients with NSCLC with EGFR-activated mutations (Photo courtesy of YSM Multimedia Team)

Post-Treatment Blood Test Could Inform Future Cancer Therapy Decisions

In the ongoing advancement of personalized medicine, a new study has provided evidence supporting the use of a tool that detects cancer-derived molecules in the blood of lung cancer patients years after... Read more

Microbiology

view channel
Image: Schematic representation illustrating the key findings of the study (Photo courtesy of UNIST)

Breakthrough Diagnostic Technology Identifies Bacterial Infections with Almost 100% Accuracy within Three Hours

Rapid and precise identification of pathogenic microbes in patient samples is essential for the effective treatment of acute infectious diseases, such as sepsis. The fluorescence in situ hybridization... Read more

Industry

view channel
Image: Tumor-associated macrophages visualized using the Multiomic LS Assay (Photo courtesy of ACD)

Leica Biosystems and Bio-Techne Expand Spatial Multiomic Collaboration

Bio-Techne Corporation (Minneapolis, MN, USA) has expanded the longstanding partnership between its spatial biology brand, Advanced Cell Diagnostics (ACD, Newark, CA, USA), and Leica Biosystems (Nussloch,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.